This study aims to evaluate the protective effects of dexmedetomidine-loaded polypeptide nanomicrospheres (PNM@Dex) in a mouse model of intestinal ischemia/reperfusion (I/R) injury and investigate the underlying molecular mechanisms, focusing on autophagy activation in enteric neurons.
Results:
PNM@Dex, synthesized via solid-phase peptide synthesis and coprecipitation, exhibited uniform spherical morphology (∼150 nm) and high drug encapsulation efficiency. In vitro studies demonstrated that PNM@Dex promoted autophagy in enteric neurons, attenuated oxidative stress and apoptosis, and improved cell viability. In vivo administration significantly mitigated intestinal injury, suppressed inflammatory cytokine production, and increased the expression of autophagy-related proteins. Autophagy inhibition assays confirmed the essential role of autophagy in mediating the protective effects of PNM@Dex.
Innovation:
This study represents the first successful incorporation of dexmedetomidine into polypeptide nanomicrospheres for targeted delivery to enteric neurons. The nanoplatform achieved sustained release, enhanced autophagy, and exerted strong anti-inflammatory and antioxidant effects, offering a novel therapeutic approach for intestinal I/R injury and potential protection in intestinal transplantation.
Conclusion:
PNM@Dex effectively alleviated intestinal I/R-induced damage through autophagy induction, oxidative stress reduction, and inflammation modulation, underscoring its promise as a therapeutic strategy for intestinal protection and transplantation. Antioxid. Redox Signal. 44, 213–235.
AhoM, ErkolaO, KallioA, et al.Comparison of dexmedetomidine and midazolam sedation and antagonism of dexmedetomidine with atipamezole. J Clin Anesth, 1993; 5(3):194–203; doi: 10.1016/0952-8180(93)90014-6
2.
AlegreF, MoragregaÁB, PoloM, et al.Role of P62/SQSTM1 beyond autophagy: A lesson learned from drug‐induced toxicity in vitro. Br J Pharmacol, 2018; 175(3):440–455; doi: 10.1111/bph.14093
3.
BellevilleJP, WardDS, BloorBC, et al.Effects of intravenous dexmedetomidine in humans. Anesthesiology, 1992; 77(6):1125–1133; doi: 10.1097/00000542-199212000-00013
4.
BonafèF, PazziniC, MarchionniS, et al.Complete disaggregation of MCF-7-Derived breast tumour spheroids with very low concentrations of α-Mangostin loaded in CD44 Thioaptamer-Tagged nanoparticles. Int J Med Sci, 2019; 16(1):33–42; doi: 10.7150/ijms.28135
5.
BurlacuC-C, NeagM-A, MitreA-O, et al.The role of MiRNAs in dexmedetomidine’s neuroprotective effects against brain disorders. Int J Mol Sci, 2022; 23(10):5452; doi: 10.3390/ijms23105452
6.
CalabreseV, ColombritaC, GuaglianoE, et al.Protective effect of carnosine during nitrosative stress in Astroglial cell cultures. Neurochem Res, 2005; 30(6–7):797–807; doi: 10.1007/s11064-005-6874-8
7.
CaoY, HuangW, WuF, et al.ZFP36 protects lungs from intestinal I/R-Induced injury and fibrosis through the CREBBP/P53/P21/Bax pathway. Cell Death Dis, 2021; 12(7):685; doi: 10.1038/s41419-021-03950-y
8.
ChenG, KangW, LiW, et al.Oral delivery of protein and peptide drugs: From non-specific formulation approaches to intestinal cell targeting strategies. Theranostics, 2022; 12(3):1419–1439; doi: 10.7150/thno.61747
9.
ChenJ, CuiY, WangZ, et al.Identification and characterization of PEDV infection in rat crypt epithelial cells. Vet Microbiol, 2020a;249:108848; doi: 10.1016/j.vetmic.2020.108848
10.
ChenR, ZhangY, LanJ, et al.Ischemic postconditioning alleviates intestinal ischemia-reperfusion injury by enhancing autophagy and suppressing oxidative stress through the Akt/GSK-3β/Nrf2 pathway in mice. Oxid Med Cell Longev, 2020b;2020:6954764–6954714; doi: 10.1155/2020/6954764
11.
ChenS, LiX, WangY, et al.Ginsenoside Rb1 attenuates intestinal ischemia/reperfusion-induced inflammation and oxidative stress via activation of the PI3K/Akt/Nrf2 signaling pathway. Mol Med Rep, 2019; 19(5):3633–3641; doi: 10.3892/mmr.2019.10018
12.
ChiuCJ, McArdleAH, BrownR, et al.Intestinal mucosal lesion in low-flow states. Arch Surg, 1970; 101(4):478–483; doi: 10.1001/archsurg.1970.01340280030009
13.
DongY, WuY, ZhaoGL, et al.Inhibition of autophagy by 3-MA promotes hypoxia-induced apoptosis in human colorectal cancer cells. Eur Rev Med Pharmacol Sci, 2019; 23(3):1047–1054; doi: 10.26355/eurrev_201902_16992
14.
EbertTJ, HallJE, BarneyJA, et al.The effects of increasing plasma concentrations of dexmedetomidine in humans. Anesthesiology, 2000; 93(2):382–394; doi: 10.1097/00000542-200008000-00016
15.
FangQ, LuX, ZhuY, et al.Development of a PCSK9-Targeted nanoparticle vaccine to effectively decrease the hypercholesterolemia. Cell Rep Med, 2024; 5(6):101614; doi: 10.1016/j.xcrm.2024.101614
16.
FengD, WangZ, ZhaoY, et al.Circ-PRKCB Acts as a CeRNA to regulate P66Shc-Mediated oxidative stress in intestinal ischemia/reperfusion. Theranostics, 2020; 10(23):10680–10696; doi: 10.7150/thno.44250
17.
FintlC, IhlerCF. The effect of sedation on D(+)‐xylose absorption tests in 6 normal horses. Equine Vet J, 2011; 43(s39):149–152; doi: 10.1111/j.2042-3306.2011.00374.x
18.
GaoY, ChenH, CangX, et al.Transplanted hair follicle mesenchymal stem cells alleviated small intestinal ischemia–reperfusion injury via intrinsic and paracrine mechanisms in a rat model. Front Cell Dev Biol, 2022; 10:1016597; doi: 10.3389/fcell.2022.1016597
19.
GerkinsC, HajjarR, OlieroM, et al.Assessment of gut barrier integrity in mice using fluorescein-isothiocyanate-labeled dextran. J Vis Exp, 2022(189); doi: 10.3791/64710
20.
GubernatorovaEO, Perez-ChanonaE, KorolevaEP, et al.Murine model of intestinal ischemia-reperfusion injury. J Vis Exp, 2016(111):53881; doi: 10.3791/53881
21.
HarfiI, D’HondtS, CorazzaF, et al.Regulation of human polymorphonuclear leukocytes functions by the neuropeptide pituitary adenylate cyclase-activating polypeptide after activation of MAPKs. J Immunol, 2004; 173(6):4154–4163; doi: 10.4049/jimmunol.173.6.4154
JiaY, CuiR, WangC, et al.Metformin protects against intestinal ischemia-reperfusion injury and cell pyroptosis via TXNIP-NLRP3-GSDMD pathway. Redox Biol, 2020; 32:101534; doi: 10.1016/j.redox.2020.101534
24.
JiangL, XiongW, YangY, et al.Insight into cardioprotective effects and mechanisms of dexmedetomidine. Cardiovasc Drugs Ther, 2024; 38(6):1139–1159; doi: 10.1007/s10557-024-07579-9
25.
JinC, FuW-L, ZhangD-D, et al.The protective role of IL-1Ra on intestinal ischemia reperfusion injury by anti-oxidative stress via Nrf2/HO-1 pathway in rat. Biomed J, 2019; 42(1):36–45; doi: 10.1016/j.bj.2018.11.001
KerriganH, FairchildSR, RichardsonM. Nanosecond laser coupling for increased filament ablation. Opt Lett, 2019; 44(10):2594–2597; doi: 10.1364/ol.44.002594
28.
LeeK-H, TsengW-C, YangC-Y, et al.The anti-inflammatory, anti-oxidative, and anti-apoptotic benefits of stem cells in acute ischemic kidney injury. Int J Mol Sci, 2019; 20(14):3529; doi: 10.3390/ijms20143529
29.
LiG, WangS, FanZ. Oxidative stress in intestinal ischemia-reperfusion. Front Med, 2022a;8; doi: 10.3389/fmed.2021.750731
30.
LiH, XiaZ, ChenY, et al.Mechanism and therapies of oxidative stress‐mediated cell death in ischemia reperfusion injury. Oxid Med Cell Longev, 2018; 2018(1):2910643; doi: 10.1155/2018/2910643
31.
LiY, FengD, WangZ, et al.Ischemia-Induced ACSL4 activation contributes to ferroptosis-mediated tissue injury in intestinal ischemia/reperfusion. Cell Death Differ, 2019; 26(11):2284–2299; doi: 10.1038/s41418-019-0299-4
32.
LiY, ZhangW, ZhaoR, et al.Advances in oral peptide drug nanoparticles for diabetes mellitus treatment. Bioact Mater, 2022b;15:392–408; doi: 10.1016/j.bioactmat.2022.02.025
33.
LiuY, JiT, JiangH, et al.Emodin alleviates intestinal ischemia–reperfusion injury through antioxidant stress, anti-inflammatory responses and anti-apoptosis effects via Akt-Mediated HO-1 upregulation. J Inflamm, 2024; 21(1); doi: 10.1186/s12950-024-00392-z
34.
MorrowJJ, BaylesI, FunnellAPW, et al.Positively selected enhancer elements endow osteosarcoma cells with metastatic competence. Nat Med, 2018; 24(2):176–185; doi: 10.1038/nm.4475
35.
NieT, WangW, LiuX, et al.Sustained release systems for delivery of therapeutic peptide/protein. Biomacromolecules, 2021; 22(6):2299–2324; doi: 10.1021/acs.biomac.1c00160
36.
PaskehMDA, AsadiA, MirzaeiS, et al.Targeting AMPK signaling in ischemic/reperfusion injury: From molecular mechanism to pharmacological interventions. Cell Signal, 2022; 94:110323; doi: 10.1016/j.cellsig.2022.110323
37.
QuaedackersJSLT, BeukRJ, BennetL, et al.An evaluation of methods for grading histologic injury following ischemia/reperfusion of the small bowel. Transplant Proc, 2000; 32(6):1307–1310; doi: 10.1016/s0041-1345(00)01238-0
38.
RunwalG, StamatakouE, SiddiqiFH, et al.LC3-Positive structures are prominent in autophagy-deficient cells. Sci Rep, 2019; 9(1):10147; doi: 10.1038/s41598-019-46657-z
39.
RussoEB, BurnettA, HallB, et al.Agonistic properties of cannabidiol at 5-HT1a receptors. Neurochem Res, 2005; 30(8):1037–1043; doi: 10.1007/s11064-005-6978-1
40.
SheR, LiuD, LiaoJ, et al.Mitochondrial dysfunctions induce PANoptosis and ferroptosis in cerebral ischemia/reperfusion injury: From pathology to therapeutic potential. Front Cell Neurosci, 2023; 17:1191629; doi: 10.3389/fncel.2023.1191629
41.
ShenX, ShiH, ChenX, et al.Esculetin alleviates inflammation, oxidative stress and apoptosis in intestinal ischemia/reperfusion injury via targeting SIRT3/AMPK/MTOR signaling and regulating autophagy. J Inflamm Res, 2023; 16:3655–3667; doi: 10.2147/jir.s413941
42.
ShiY, JiangB, ZhaoJ. Induction mechanisms of autophagy and endoplasmic reticulum stress in intestinal ischemia-reperfusion injury, inflammatory bowel disease, and colorectal cancer. Biomed Pharmacother, 2024; 170:115984; doi: 10.1016/j.biopha.2023.115984
43.
SoaresROS, LosadaDM, JordaniMC, et al.Ischemia/Reperfusion injury revisited: An overview of the latest pharmacological strategies. Int J Mol Sci, 2019; 20(20):5034; doi: 10.3390/ijms20205034
44.
SunM, WangR, XiaR, et al.Amelioration of myocardial ischemia/reperfusion injury in diabetes: A narrative review of the mechanisms and clinical applications of dexmedetomidine. Front Pharmacol, 2022; 13:949754; doi: 10.3389/fphar.2022.949754
45.
TahaAM, MahmoudAM, GhonaimMM, et al.Melatonin as a potential treatment for septic cardiomyopathy. Biomed Pharmacother, 2023; 166:115305; doi: 10.1016/j.biopha.2023.115305
46.
TangZ, MaQ, ChenX, et al.Recent advances and challenges in nanodelivery systems for Antimicrobial Peptides (AMPs). Antibiotics (Basel), 2021; 10(8):990; doi: 10.3390/antibiotics10080990
47.
TranS, FairlieWD, LeeEF. BECLIN1: Protein structure, function and regulation. Cells, 2021; 10(6):1522; doi: 10.3390/cells10061522
48.
WangJ, ZhangW, WuG. Intestinal ischemic reperfusion injury: Recommended rats model and comprehensive review for protective strategies. Biomed Pharmacother, 2021; 138:111482; doi: 10.1016/j.biopha.2021.111482
49.
WangL, DingY, BaiY, et al.The activation of SIRT3 by dexmedetomidine mitigates limb ischemia-reperfusion–induced lung injury. Ann Transl Med, 2022; 10(6):319; doi: 10.21037/atm-22-711
50.
WangQ, XueX, WangP, et al.Angiotensin 1 peptide-conjugated CdSe/ZnS quantum dots for cardiac-specific hydrogen sulfide targeted therapy in myocardial ischemia-reperfusion injury. Front Pharmacol, 2024; 15:1435282; doi: 10.3389/fphar.2024.1435282
51.
WangY, JiangH, ZhangL, et al.Nanosystems for oxidative stress regulation in the anti-inflammatory therapy of acute kidney injury. Front Bioeng Biotechnol, 2023; 11:1120148; doi: 10.3389/fbioe.2023.1120148
52.
WuQ, ChenQ, LiangS, et al.Dexmedetomidine alleviates intestinal ischemia/reperfusion injury by modulating intestinal neuron autophagy and mitochondrial homeostasis via Nupr1 regulation. Mol Med, 2024; 30(1):203; doi: 10.1186/s10020-024-00952-2
53.
XuG, MaY, JinJ, et al.Activation of AMPK/P38/Nrf2 is involved in resveratrol alleviating myocardial ischemia-reperfusion injury in diabetic rats as an endogenous antioxidant stress feedback. Ann Transl Med, 2022; 10(16):890; doi: 10.21037/atm-22-3789
54.
XuH, ShenJ, XiaoJ, et al.Neuroprotective effect of cajaninstilbene acid against cerebral ischemia and reperfusion damages by activating AMPK/Nrf2 pathway. J Adv Res, 2021; 34:199–210; doi: 10.1016/j.jare.2020.07.011
55.
YangT, FengX, ZhaoY, et al.Dexmedetomidine enhances autophagy via Α2-AR/AMPK/MTOR pathway to inhibit the activation of NLRP3 inflammasome and subsequently alleviates lipopolysaccharide-induced acute kidney injury. Front Pharmacol, 2020; 11:790; doi: 10.3389/fphar.2020.00790
56.
YiS, CaoH, ZhengW, et al.Targeting the opioid remifentanil: Protective effects and molecular mechanisms against organ ischemia-reperfusion injury. Biomed Pharmacother, 2023; 167:115472; doi: 10.1016/j.biopha.2023.115472
57.
ZashikhinaN, GladnevS, SharoykoV, et al.Synthesis and characterization of nanoparticle-based dexamethasone-polypeptide conjugates as potential intravitreal delivery systems. Int J Mol Sci, 2023; 24(4):3702; doi: 10.3390/ijms24043702
58.
ZengX, JiangS, WuY, et al.Regulatory role of AMPK/Nrf2 signaling pathway in sevoflurane-enhanced intestinal protection against ischemia-reperfusion injury. Int J Biochem Cell Biol, 2024; 177:106702; doi: 10.1016/j.biocel.2024.106702
59.
ZhangS, PengB, ChenZ, et al.Brain-Targeting, acid-responsive antioxidant nanoparticles for stroke treatment and drug delivery. Bioact Mater, 2022; 16:57–65; doi: 10.1016/j.bioactmat.2022.02.033
60.
ZhangY, WeiH, WangM, et al.Dexmedetomidine alleviates ferroptosis following hepatic ischemia-reperfusion injury by upregulating Nrf2/GPx4-Dependent antioxidant responses. Biomed Pharmacother, 2023; 169:115915; doi: 10.1016/j.biopha.2023.115915
61.
ZhaoT, WuW, SuiL, et al.Reactive oxygen species-based nanomaterials for the treatment of myocardial ischemia reperfusion injuries. Bioact Mater, 2022; 7:47–72; doi: 10.1016/j.bioactmat.2021.06.006
ZuG, ZhouT, CheN, et al.Salvianolic acid a protects against oxidative stress and apoptosis induced by intestinal ischemia-reperfusion injury through activation of Nrf2/HO-1 pathways. Cell Physiol Biochem, 2018; 49(6):2320–2332; doi: 10.1159/000493833
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
